Body weight independent effects of CT-868, a signalling biased dual GLP-1/GIP receptor modulator, on glucose homeostasis in overweight and obese adults with type 2 diabetes

Publication Authors:

M. Chakravarthy, M. Hernandez, M. Elliott, A. Macias, S. Hansen1, M. Hompesch

Presented at EASD 2023, October 2-6, 2023

About

View abstract here.

Body weight independent effects of CT-868, a signalling biased dual GLP-1/GIP receptor modulator, on glucose homeostasis in overweight and obese adults with type 2 diabetes thumbnail